Carcinogenic risk in patients treated with UVA‐1 phototherapy: A 5‐year retrospective study
Photoaging
Morphea
DOI:
10.1111/phpp.12975
Publication Date:
2024-05-24T17:58:56Z
AUTHORS (4)
ABSTRACT
UVA-1 phototherapy was first used to treat atopic dermatitis and afterwards several other skin diseases. The contribution of in human photocarcinogenesis, photoaging, immune suppression, hyperpigmentation is now well established. actual radiation the development malignant melanoma (MM) humans cannot be excluded.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....